Low total testosterone despite low SHBG indicates reduced testosterone production.

In a 49-year-old female, evaluating circulating androgen levels requires a careful distinction between altered carrier-protein binding and true synthetic deficiency.

Mechanistic explanations

• Carrier Protein Dynamics: Sex hormone-binding globulin (SHBG) is the primary high-affinity carrier protein for circulating testosterone, dictating the balance between carrier-bound and biologically active free fractions. Low levels of SHBG reduce the available high-affinity binding sites, which initially increases the free (unbound) fraction of circulating testosterone.
• Clearance vs. Synthesis: An elevated free fraction allows for greater tissue uptake and accelerates the apparent metabolic clearance rate of the hormone. While isolated low SHBG typically decreases total testosterone due to this rapid clearance (while keeping free levels relatively preserved), a persistent depression of both markers indicates a deeper systemic issue.

Clinical implications and indicators

• True Androgen Deficiency: When total testosterone remains low in the setting of low SHBG, total and free testosterone levels move closer together. This dual depression, particularly when metabolic conditions like insulin resistance or obesity are ruled out, serves as a strong clinical indicator of diminished ovarian or adrenal androgen synthesis rather than a binding artifact.
• Adrenal Precursor Support: This state of reduced production is often corroborated by low levels of dehydroepiandrosterone sulfate (DHEAS). Because DHEAS is a key adrenal precursor, its depletion limits peripheral conversion into testosterone, confirming a primary or secondary synthetic failure.

Bottom line

• A clinical presentation of low total testosterone despite low SHBG points directly to reduced testosterone production rather than an anomaly of protein binding. While isolated low SHBG lowers total testosterone by accelerating metabolic clearance, a concurrent deficit in both parameters reflects an absolute reduction in androgen synthesis.